Prosecution Insights
Prosecution Insights
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WISTNER, SARAH CLINKSCALES | 1 | 21.7% | +74.4% |
| ROMANOWSKI, MICHAEL C | 1 | 53.6% | +61.9% |
| PEO, KARA M | 1 | 42.2% | +39.6% |
| CHATRATHI, ARJUNA P | 1 | 63.0% | +21.2% |
| STIMPERT, PHILIP EARL | 1 | 62.8% | +49.5% |
| CORDAS, EMILY ANN | 1 | 50.4% | +58.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18010992 | PACKAGES COMPRISING ANTI-MICROBIAL COATINGS FOR PREVENTING CONTAMINATION, E.G. AFTER FIRST USE OF THE PRODUCT | STIMPERT, PHILIP EARL | 5d overdue |
| 18579677 | PRESERVATIVE COMPOSITION FOR NUCLEIC ACIDS AND BIOLOGICAL SAMPLES AND METHODS OF USE | WISTNER, SARAH CLINKSCALES | — |
| 18018868 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | PEO, KARA M | — |
| 17920271 | NUCLEIC ACID AND CELL PRESERVATIVE COMPOSITIONS AND METHODS OF USE | CORDAS, EMILY ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18012588 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | CHATRATHI, ARJUNA P | 45d overdue |
| 18010992 | PACKAGES COMPRISING ANTI-MICROBIAL COATINGS FOR PREVENTING CONTAMINATION, E.G. AFTER FIRST USE OF THE PRODUCT | STIMPERT, PHILIP EARL | 5d overdue |
| 18579677 | PRESERVATIVE COMPOSITION FOR NUCLEIC ACIDS AND BIOLOGICAL SAMPLES AND METHODS OF USE | WISTNER, SARAH CLINKSCALES | — |
| 18498734 | STERILIZABLE PHARMACEUTICAL PACKAGE FOR OPHTHALMIC FORMULATIONS | ROMANOWSKI, MICHAEL C | — |
| 18018868 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | PEO, KARA M | — |
| 17920271 | NUCLEIC ACID AND CELL PRESERVATIVE COMPOSITIONS AND METHODS OF USE | CORDAS, EMILY ANN | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| 1782 | 1 |
| 1777 | 1 |
| 3781 | 1 |
| 3783 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18579677 | PRESERVATIVE COMPOSITION FOR NUCLEIC ACIDS AND BIOLOGICAL SAMPLES AND METHODS OF USE | WISTNER, SARAH CLINKSCALES | 1616 | §103§112DP | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18498734 | STERILIZABLE PHARMACEUTICAL PACKAGE FOR OPHTHALMIC FORMULATIONS | ROMANOWSKI, MICHAEL C | 1782 | §103 | Final Rejection | — | Pending | Oct 31, 2023 |
| 18018868 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | PEO, KARA M | 1777 | §102§112 | Non-Final OA | — | Pending | Jan 30, 2023 |
| 18012588 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | CHATRATHI, ARJUNA P | 3781 | §103 | Non-Final OA | 45d overdue | Pending | Dec 22, 2022 |
| 18010992 | PACKAGES COMPRISING ANTI-MICROBIAL COATINGS FOR PREVENTING CONTAMINATION, E.G. AFTER FIRST USE OF THE PRODUCT | STIMPERT, PHILIP EARL | 3783 | §102§103§112 | Final Rejection | 5d overdue | Pending | Dec 16, 2022 |
| 17920271 | NUCLEIC ACID AND CELL PRESERVATIVE COMPOSITIONS AND METHODS OF USE | CORDAS, EMILY ANN | 1632 | §103§112 | Final Rejection | — | Pending | Oct 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial